{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-215227","form_type":"8-K","ticker":"PBYI","cik":"0001401667","company_name":"PUMA BIOTECHNOLOGY, INC.","filed_at":"2021-07-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.953450+00:00","generated_at":"2026-06-30T05:21:51.417959+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Puma Biotechnology appoints Allison Dorval to board of directors","bullets":["Appointment effective July 15, 2021; term expires at 2022 annual meeting.","Dorval also appointed to the Audit Committee.","Currently CFO of Voyager Therapeutics (since Nov 2018); CPA with life sciences background.","Will receive standard non-employee director compensation and indemnification agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-215227","json":"https://secwatch.observer/filing/0001193125-21-215227.json","markdown":"https://secwatch.observer/filing/0001193125-21-215227.md","text":"https://secwatch.observer/filing/0001193125-21-215227.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401667/000119312521215227/0001193125-21-215227-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401667/000119312521215227/d119549d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T05:21:51.417959+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"242e7a6dbf","claim":"Allison Dorval was appointed as Director at PUMA BIOTECHNOLOGY, INC..","evidence_excerpt":"On July 8, 2021, Allison Dorval, 45, was appointed to the Board of Directors (the “Board”) of Puma Biotechnology, Inc. (the “Company”), effective July 15, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401667/000119312521215227/0001193125-21-215227-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}